Dirk Schnappinger
Affiliations: | Weill Cornell Medical College, New York, NY, United States |
Area:
Microbiology BiologyGoogle:
"Dirk Schnappinger"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sharma R, Hartman TE, Beites T, et al. (2023) Metabolically distinct roles of NAD synthetase and NAD kinase define the essentiality of NAD and NADP in . Mbio. e0034023 |
| Green SR, Davis SH, Damerow S, et al. (2022) Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs. Nature Communications. 13: 5992 |
| Li S, Poulton NC, Chang JS, et al. (2022) CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis. Nature Microbiology. 7: 766-779 |
| Kreutzfeldt KM, Jansen RS, Hartman TE, et al. (2022) CinA mediates multidrug tolerance in Mycobacterium tuberculosis. Nature Communications. 13: 2203 |
| Beites T, Jansen RS, Wang R, et al. (2021) Multiple acyl-CoA dehydrogenase deficiency kills Mycobacterium tuberculosis in vitro and during infection. Nature Communications. 12: 6593 |
| Bosch B, DeJesus MA, Poulton NC, et al. (2021) Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis. Cell |
| Wang H, Xu M, Engelhart CA, et al. (2021) Rediscovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in Mycobacterium tuberculosis. The Journal of Biological Chemistry. 296: 100257 |
| Ray PC, Huggett M, Turner PA, et al. (2021) Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Growth. Acs Omega. 6: 2284-2311 |
| Wang H, Xu M, Engelhart CA, et al. (2021) Re-discovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in . The Journal of Biological Chemistry |
| Lee BS, Hards K, Engelhart CA, et al. (2020) Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis. Embo Molecular Medicine. e13207 |